Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Weber

Showing results (251-260 of 316) with videos related to

Pageof 32
Sort By:
Frontiers in Neurology|April 12, 2019
ROCK-ALS: Protocol for a Randomized, Placebo-Controlled, Double-Blind Phase IIa Trial of Safety, Tolerability and Efficacy of the Rho Kinase (ROCK) Inhibitor Fasudil in Amyotrophic Lateral SclerosisPaul Lingor, Markus Weber, William Camu, et al.
Science Translational Medicine|December 7, 2018
A human-derived antibody targets misfolded SOD1 and ameliorates motor symptoms in mouse models of amyotrophic lateral sclerosisMarcel Maier, Tobias Welt, Fabian Wirth, et al.
Plos One|September 22, 2017
The association between acute graft-versus-host disease and antimicrobial peptide expression in the gastrointestinal tract after allogeneic stem cell transplantationDaniela Weber, Katrin Frauenschläger, Sakhila Ghimire, et al.
Neurobiology of Disease|September 6, 2011
The modulation of Amyotrophic Lateral Sclerosis risk by ataxin-2 intermediate polyglutamine expansions is a specific effectSuzana Gispert, Alexander Kurz, Stefan Waibel, et al.
The British Journal of Surgery|December 1, 2021
Effects of structured intraoperative briefings on patient outcomes: multicentre before-and-after studyFranziska Tschan, Sandra Keller, Norbert K Semmer, et al.
Human Molecular Genetics|February 5, 2011
Ataxin-2 intermediate-length polyglutamine expansions in European ALS patientsTeresa Lee, Yun R Li, Caroline Ingre, et al.
Haematologica|June 1, 2023
Intestinal IgA-positive plasma cells are highly sensitive indicators of alloreaction early after allogeneic transplantation and associate with both graft-versus-host disease and relapse-related mortalityLucia Scheidler, Katrin Hippe, Sakhila Ghimire, et al.
Journal of Neurology|January 26, 2015
Percutaneous endoscopic gastrostomy in amyotrophic lateral sclerosis: a prospective observational studyJohannes Dorst, Luc Dupuis, Susanne Petri, et al.
European Journal of Neurology|September 15, 2011
EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)--revised report of an EFNS task force, Peter M Andersen, Sharon Abrahams, et al.
European Journal of Neurology|March 11, 2024
Cervical and thoracic spinal cord gray matter atrophy is associated with disability in patients with amyotrophic lateral sclerosisMaria Janina Wendebourg, Matthias Weigel, Claudia Weidensteiner, et al.
Pageof 32

Showing results (251-260 of 316) with videos related to

Sort By:
Pageof 32
Frontiers in Neurology|April 12, 2019
ROCK-ALS: Protocol for a Randomized, Placebo-Controlled, Double-Blind Phase IIa Trial of Safety, Tolerability and Efficacy of the Rho Kinase (ROCK) Inhibitor Fasudil in Amyotrophic Lateral SclerosisPaul Lingor, Markus Weber, William Camu, et al.
Science Translational Medicine|December 7, 2018
A human-derived antibody targets misfolded SOD1 and ameliorates motor symptoms in mouse models of amyotrophic lateral sclerosisMarcel Maier, Tobias Welt, Fabian Wirth, et al.
Plos One|September 22, 2017
The association between acute graft-versus-host disease and antimicrobial peptide expression in the gastrointestinal tract after allogeneic stem cell transplantationDaniela Weber, Katrin Frauenschläger, Sakhila Ghimire, et al.
Neurobiology of Disease|September 6, 2011
The modulation of Amyotrophic Lateral Sclerosis risk by ataxin-2 intermediate polyglutamine expansions is a specific effectSuzana Gispert, Alexander Kurz, Stefan Waibel, et al.
The British Journal of Surgery|December 1, 2021
Effects of structured intraoperative briefings on patient outcomes: multicentre before-and-after studyFranziska Tschan, Sandra Keller, Norbert K Semmer, et al.
Human Molecular Genetics|February 5, 2011
Ataxin-2 intermediate-length polyglutamine expansions in European ALS patientsTeresa Lee, Yun R Li, Caroline Ingre, et al.
Haematologica|June 1, 2023
Intestinal IgA-positive plasma cells are highly sensitive indicators of alloreaction early after allogeneic transplantation and associate with both graft-versus-host disease and relapse-related mortalityLucia Scheidler, Katrin Hippe, Sakhila Ghimire, et al.
Journal of Neurology|January 26, 2015
Percutaneous endoscopic gastrostomy in amyotrophic lateral sclerosis: a prospective observational studyJohannes Dorst, Luc Dupuis, Susanne Petri, et al.
European Journal of Neurology|September 15, 2011
EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)--revised report of an EFNS task force, Peter M Andersen, Sharon Abrahams, et al.
European Journal of Neurology|March 11, 2024
Cervical and thoracic spinal cord gray matter atrophy is associated with disability in patients with amyotrophic lateral sclerosisMaria Janina Wendebourg, Matthias Weigel, Claudia Weidensteiner, et al.
Pageof 32